机构:[1]Beijing Tiantan Hospital, Capital Medical University, Department of Neurology, Beijing, China重点科室诊疗科室神经病学中心首都医科大学附属天坛医院[2]China National Clinical Research Center for Neurological Diseases, Beijing, China[3]Beijing Tiantan Hospital, Capital Medical University, Beijing, China首都医科大学附属天坛医院[4]Peking Union Medical College Hospital, Department of Neurology, Beijing, China
第一作者机构:[1]Beijing Tiantan Hospital, Capital Medical University, Department of Neurology, Beijing, China[2]China National Clinical Research Center for Neurological Diseases, Beijing, China
推荐引用方式(GB/T 7714):
Li C.,Shi W.,Chen C.,et al.The Clinical Features And Immunotherapy Outcomes Of Glutamic Acid Decarboxylase 65 Antibody Associated Neurological Disorders[J].EPILEPSIA.2019,60:125-126.
APA:
Li, C.,Shi, W.,Chen, C.,Pan, H.,Jian, F....&Shao, X..(2019).The Clinical Features And Immunotherapy Outcomes Of Glutamic Acid Decarboxylase 65 Antibody Associated Neurological Disorders.EPILEPSIA,60,
MLA:
Li, C.,et al."The Clinical Features And Immunotherapy Outcomes Of Glutamic Acid Decarboxylase 65 Antibody Associated Neurological Disorders".EPILEPSIA 60.(2019):125-126